ALLR

Conviction 41HealthcareScan · Mon, Aug 10, 2026

ALLR$1.41+1.44%

ResistanceSupportVol 14

Vol MA14 63.17K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Allarity Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.allarity.com ↗

Price1.41

Change+1.44%

Gap+0.72%

Rel volume0.78×

Avg volume68.25K

Avg $ vol85.07K

SMA 201.25

SMA 501.34

SMA 2001.23

Price vs 50+5.31%

Price vs 200+14.64%

MA stackbullish

50/200 cross—

Supertrenddown · 1.45

RSI (14)62

MACD hist0.03

MACD cross—

Stoch %K / %D93 / 93

ADX (14)23

+DI / −DI19 / 13

RSI divergenceBullish

MACD divergenceBullish

ATR %+5.97%

ADR %5.96%

52w high1.97

52w low0.8100

From 52w high-28.43%

Above 52w low+74.07%

New 52w highNo

SqueezeOff

Bollinger width25.77%

%B1.01

Donchian pos93.65%

Donchian high1.43

Donchian low1.12

AVWAP (52w high)1.68

vs AVWAP high-16.01%

AVWAP (52w low)1.30

vs AVWAP low+8.57%

OBV trendUp

Chaikin MF (20)0.07

Today vs 20d0.78×

Avg vol (14d)63.17K

Avg vol (20d)68.25K

Avg $ vol (20d)85.07K

Market cap22.43M

RS 3m (vs SPY)-13.03%

RS 6m (vs SPY)+57.49%

RS line new highNo

Trend template5/8

Technical rank85.4

1 week+11.02%

1 month+21.03%

3 months-9.03%

6 months+69.74%

1 year+42.94%

YTD+23.68%

P/E-2.00

P/B3.24

P/S70.11

P/FCF-1.51

EPS-10.26

Div yield—

ROE-162.30%

ROA-32.16%

Debt/Eq0.42

Current1.23

EV/EBITDA-0.44

Gross margin-707.81%

Net margin—

Rev growth—

EPS growth54.19%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value5.56M

Revenue25K

Net income-2.75M

Gross profit-1.25M

Free cash flow-14.83M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out15.91M

Employees8

ListedTue, Dec 21, 2021

Free float15.79M

Float %99.8%

Short interest145.81K

Days to cover1.0d

Short volume29.9%

Squeeze score7 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction41 / 100

Pattern quality—

Tech rank85.4 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.46

Support1.09

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ALLR

All disclosures →

No recent disclosed trades by Congress in ALLR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ALLR · 3 buys

Insider	Side	Shares	Value	Traded	Filed
Jensen Thomas CEO · Common Stock · 2026-01-28	Grant	200K	$0	2026-01-28	2026-05-14
Hoeiland Jesper Director · Common Stock · 2026-01-07	Grant	25K	$0	2026-01-07	2026-05-11
McLaughlin Gerald W. Director · Common Stock · 2026-01-28	Grant	45K	$0	2026-01-28	2026-05-07

SEC filings

EDGAR filings in ALLR · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.